Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma

被引:110
作者
Shintani, S [1 ]
Li, CN [1 ]
Ishikawa, T [1 ]
Mihara, M [1 ]
Nakashiro, K [1 ]
Hamakawa, H [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Oral & Maxillofacial Surg, Shigenobu, Ehime 7910295, Japan
关键词
vascular endothelial growth factor; angiogenesis; lymph node metastasis; oral squamous cell carcinoma;
D O I
10.1016/S1368-8375(03)00127-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor (VEGF) A is known to play an important role in tumor angiogenesis. The additional members of the VEGF family, VEGF B, C and D have been discovered. VEGF C and D show some selectivity toward lymphatic endothelial cells. However, whether VEGF family members play a role in tumor angiogenesis and lymph node metastasis is largely unknown. The aim of the present study was to explore the role of VEGF family members in oral squamous cell carcinoma (OSCC). We evaluated the expression of VEGF family members by immunohistochemistry, reverse transcription-polymerase chain reaction, and western blotting. All VEGF members were expressed at different levels in OSCC. Immunohistological analysis of VEGF family members expression and microvessel density revealed a correlation between VEGF A and B expression and tumor angiogenesis. Although VEGF A and B expression were detected in both node-positive and node-negative OSCC, VEGF C and D expression was detected frequently in node-positive tumors compared to node-negative tumors. These findings suggest a possible relationship between the expression level of VEGF C and/or D and development of lymphatic tumor spread. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 35 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]  
ANNEROTH G, 1987, SCAND J DENT RES, V95, P229
[3]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[4]   VEGF(121), A VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ISOFORM LACKING HEPARIN-BINDING ABILITY, REQUIRES CELL-SURFACE HEPARAN SULFATES FOR EFFICIENT BINDING TO THE VEGF RECEPTORS OF HUMAN-MELANOMA CELLS [J].
COHEN, T ;
GITAYGOREN, H ;
SHARON, R ;
SHIBUYA, M ;
HALABAN, R ;
LEVI, BZ ;
NEUFELD, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11322-11326
[5]   Angiogenesis and metastasis [J].
Ellis, LM ;
Fidler, IJ .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2451-2460
[6]   THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].
FIDLER, IJ ;
ELLIS, LM .
CELL, 1994, 79 (02) :185-188
[7]  
JEITSCH M, 1997, SCIENCE, V276, P1423
[8]  
Joukov V, 1997, J CELL PHYSIOL, V173, P211, DOI 10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO
[9]  
2-H
[10]   Proteolytic processing regulates receptor specificity and activity of VEGF-C [J].
Joukov, V ;
Sorsa, T ;
Kumar, V ;
Jeltsch, M ;
ClaessonWelsh, L ;
Cao, YH ;
Saksela, O ;
Kalkkinen, N ;
Alitalo, K .
EMBO JOURNAL, 1997, 16 (13) :3898-3911